Skip to main content
. 2013 Aug 20;19(6):535–545. doi: 10.1089/ars.2012.4580

FIG. 3.

FIG. 3.

Arterial and venous plasma concentrations of 15(S)-8-iso-prostaglandin F2α. (A) Arterial and renal venous plasma 15(S)-8-iso-PGF2α concentrations during the first 30 min of reperfusion in living donor (LD) kidney transplantation showed a small, but significant release from the kidney (p=0.03); (B) In deceased donor (DD) kidney transplantation, 15(S)-8-iso-PGF2α was not released from the reperfused kidney during the first 30 min of reperfusion (p=0.16); (C) Arterial and myocardial venous plasma 15(S)-8-iso-PGF2α concentrations during the first 60 min of reperfusion in patients with preexisting heart failure showed a small, but significant release from the myocardium (p=0.02); (D) In patients without preexisting heart failure, 15(S)-8-iso-PGF2α was not released from the reperfused heart during the first 60 min of reperfusion (p=0.18).